Literature DB >> 1722394

Prostaglandin-concentration-dependent desensitization of adenylate cyclase in human erythroleukaemia (HEL) cells is abolished by pertussis toxin and enhanced by induction by dimethyl sulphoxide.

B Ashby1, G O Almonor, E Wernick, M A Selak.   

Abstract

Prostaglandin-regulated cyclic AMP metabolism in human erythroleukaemia (HEL) cells was similar to that previously described in platelets [Ashby (1989) Mol. Pharmacol. 36, 866-873], displaying prostaglandin-concentration-dependent desensitization that could be explained by the presence of separate stimulatory and inhibitory prostaglandin receptors. Pertussis toxin abolished prostaglandin-concentration-dependent desensitization, indicating that the process is mediated through a pertussis toxin-sensitive GTP-binding protein. Treatment of HEL cells for 4 days with the inducer dimethyl sulphoxide enhanced prostaglandin-concentration-dependent desensitization, but did not alter the initial rate of cyclic AMP synthesis or the amount of Gi2 alpha measured by immunoblotting, suggesting that the inhibitory receptor was selectively induced by changing the cells to a more platelet-like form.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722394      PMCID: PMC1130525          DOI: 10.1042/bj2800801

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

Review 1.  Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.

Authors:  S Moncada; J R Vane
Journal:  Pharmacol Rev       Date:  1978-09       Impact factor: 25.468

2.  Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.

Authors:  K A Williams; W Murphy; R J Haslam
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

3.  Receptors for PGI2 and PGD2 on human platelets.

Authors:  A M Siegl
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

4.  Protein kinase C interferes with Ni-mediated inhibition of human platelet adenylate cyclase.

Authors:  Y Watanabe; F Horn; S Bauer; K H Jakobs
Journal:  FEBS Lett       Date:  1985-11-11       Impact factor: 4.124

5.  Modulation of adenylate cyclase of human platelets by phorbol ester. Impairment of the hormone-sensitive inhibitory pathway.

Authors:  K H Jakobs; S Bauer; Y Watanabe
Journal:  Eur J Biochem       Date:  1985-09-02

6.  Turnover of adenosine 3',5'-monophosphate in WI-38 cultured fibroblasts.

Authors:  R Barber; K P Ray; R W Butcher
Journal:  Biochemistry       Date:  1980-06-10       Impact factor: 3.162

7.  Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.

Authors:  B Ashby
Journal:  Mol Pharmacol       Date:  1990-07       Impact factor: 4.436

8.  Cyclic AMP turnover in response to prostaglandins in intact platelets: evidence for separate stimulatory and inhibitory prostaglandin receptors.

Authors:  B Ashby
Journal:  Second Messengers Phosphoproteins       Date:  1988

9.  Expression of thromboxane A2 receptor in cultured human erythroleukemia cells and its induction by 12-O-tetradecanoylphorbol-13-acetate.

Authors:  M Nakajima; M Yamamoto; F Ushikubi; M Okuma; M Fujiwara; S Narumiya
Journal:  Biochem Biophys Res Commun       Date:  1989-02-15       Impact factor: 3.575

10.  Expression of platelet membrane glycoproteins and alpha-granule proteins by a human erythroleukemia cell line (HEL).

Authors:  A Tabilio; J P Rosa; U Testa; N Kieffer; A T Nurden; M C Del Canizo; J Breton-Gorius; W Vainchenker
Journal:  EMBO J       Date:  1984-02       Impact factor: 11.598

View more
  4 in total

1.  Rapid desensitization of adrenaline- and neuropeptide Y-stimulated Ca2+ mobilization in HEL-cells.

Authors:  M C Michel
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

2.  G-protein-coupled receptors in normal human erythroid progenitor cells.

Authors:  H Porzig; R Gutknecht; G Kostova; K Thalmeier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

3.  Prostacyclin-dependent cyclic AMP formation in endothelial cells.

Authors:  H Schröder; K Schrör
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-01       Impact factor: 3.000

4.  Cloning and expression of a prostaglandin E receptor EP3 subtype from human erythroleukaemia cells.

Authors:  S P Kunapuli; G Fen Mao; M Bastepe; L Y Liu-Chen; S Li; P P Cheung; J K DeRiel; B Ashby
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.